Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen obesity therapy ...
Die Ypsomed Holding verzeichnet aktuell eine leichte Marktkorrektur. Am 25. November 2024 notierte die Aktie bei 385,00 EUR, was einem Tagesverlust von 0,19 Prozent entspricht. Der ...
Now, a partnership between Ypsomed and Sidekick Heath aims to tackle that problem. Ypsomed is a top developer of injection and infusion systems, so knows a lot about the difficulties that patients ...
17.10.24 finanzen.netSPI-Wert Ypsomed-Aktie: So viel Gewinn hätte ein Investment in Ypsomed von vor 3 Jahren abgeworfen ...
Becton, Dickinson and Company announced a strategic collaboration with Ypsomed, a developer of injection systems, to advance self-injection solutions for high-viscosity biologic drugs.
Global medical technology company BD has entered into a strategic partnership with Ypsomed, an injection systems manufacturer, to advance self-injection solutions specifically designed for high ...
So on that note, Ypsomed Holding (VTX:YPSN) looks quite promising in regards to its trends of return on capital. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit ...
So on that note, Ypsomed Holding (VTX:YPSN) looks quite promising in regards to its trends of return on capital. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback